IHS Chemical Week

EnviroTech :: Alternative fuels

Verenium: Analyst Highlights Risk of Plant Delay

10:20 AM MDT | June 8, 2009 | Alex Scott

Verenium (Cambridge, MA) a biotech start up, faces the risk of a delay in the construction of its planned commercial cellulosic ethanol facility as well as risks to its enzymes business, says Laurence Alexander, an analyst with Jefferies & Co. (New York), in a recent report. Alexander suggests that when looking at Verenium as an investment option, that there are “better risk-rewards available elsewhere.” Alexander’s report follows a recent meeting with Verenium’s president and CEO Carlos Riva, and CFO James Levine.   Issues...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa